Clinical application of oligodendrocyte precursor cells for cell-based therapy

Oligodendrocyte precursor cells (OPCs), which give rise to mature oligodendrocytes (OLs), play important roles in maintaining white matter function. Even during the adulthood period, OPCs comprise roughly 5% of all cells in the forebrain and retain a capability to become myelinated OLs. Recently, OP...

Full description

Bibliographic Details
Main Authors: Naohiro Egawa, Hajime Takase, Lok Josephine, Ryosuke Takahashi, Ken Arai
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Brain Circulation
Subjects:
Online Access:http://www.braincirculation.org/article.asp?issn=2394-8108;year=2016;volume=2;issue=3;spage=121;epage=125;aulast=Egawa
_version_ 1819129730919563264
author Naohiro Egawa
Hajime Takase
Lok Josephine
Ryosuke Takahashi
Ken Arai
author_facet Naohiro Egawa
Hajime Takase
Lok Josephine
Ryosuke Takahashi
Ken Arai
author_sort Naohiro Egawa
collection DOAJ
description Oligodendrocyte precursor cells (OPCs), which give rise to mature oligodendrocytes (OLs), play important roles in maintaining white matter function. Even during the adulthood period, OPCs comprise roughly 5% of all cells in the forebrain and retain a capability to become myelinated OLs. Recently, OPCs have been proposed as a novel source for cell-based therapy. For the purpose, OPCs can be obtained from embryonic stem cells, induced pluripotent stem cells, and directly converted cells derived from patients. Here, we will provide a brief review of the potential of using OPCs as a cell-based therapy for treating various neurological diseases.
first_indexed 2024-12-22T08:48:22Z
format Article
id doaj.art-8c06d926673c4e8093b9131cb80a8498
institution Directory Open Access Journal
issn 2455-4626
language English
last_indexed 2024-12-22T08:48:22Z
publishDate 2016-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Brain Circulation
spelling doaj.art-8c06d926673c4e8093b9131cb80a84982022-12-21T18:32:02ZengWolters Kluwer Medknow PublicationsBrain Circulation2455-46262016-01-012312112510.4103/2394-8108.192515Clinical application of oligodendrocyte precursor cells for cell-based therapyNaohiro EgawaHajime TakaseLok JosephineRyosuke TakahashiKen AraiOligodendrocyte precursor cells (OPCs), which give rise to mature oligodendrocytes (OLs), play important roles in maintaining white matter function. Even during the adulthood period, OPCs comprise roughly 5% of all cells in the forebrain and retain a capability to become myelinated OLs. Recently, OPCs have been proposed as a novel source for cell-based therapy. For the purpose, OPCs can be obtained from embryonic stem cells, induced pluripotent stem cells, and directly converted cells derived from patients. Here, we will provide a brief review of the potential of using OPCs as a cell-based therapy for treating various neurological diseases.http://www.braincirculation.org/article.asp?issn=2394-8108;year=2016;volume=2;issue=3;spage=121;epage=125;aulast=EgawaCell transplantationoligodendrocyte precursor cellsstem cell therapy
spellingShingle Naohiro Egawa
Hajime Takase
Lok Josephine
Ryosuke Takahashi
Ken Arai
Clinical application of oligodendrocyte precursor cells for cell-based therapy
Brain Circulation
Cell transplantation
oligodendrocyte precursor cells
stem cell therapy
title Clinical application of oligodendrocyte precursor cells for cell-based therapy
title_full Clinical application of oligodendrocyte precursor cells for cell-based therapy
title_fullStr Clinical application of oligodendrocyte precursor cells for cell-based therapy
title_full_unstemmed Clinical application of oligodendrocyte precursor cells for cell-based therapy
title_short Clinical application of oligodendrocyte precursor cells for cell-based therapy
title_sort clinical application of oligodendrocyte precursor cells for cell based therapy
topic Cell transplantation
oligodendrocyte precursor cells
stem cell therapy
url http://www.braincirculation.org/article.asp?issn=2394-8108;year=2016;volume=2;issue=3;spage=121;epage=125;aulast=Egawa
work_keys_str_mv AT naohiroegawa clinicalapplicationofoligodendrocyteprecursorcellsforcellbasedtherapy
AT hajimetakase clinicalapplicationofoligodendrocyteprecursorcellsforcellbasedtherapy
AT lokjosephine clinicalapplicationofoligodendrocyteprecursorcellsforcellbasedtherapy
AT ryosuketakahashi clinicalapplicationofoligodendrocyteprecursorcellsforcellbasedtherapy
AT kenarai clinicalapplicationofoligodendrocyteprecursorcellsforcellbasedtherapy